Nature Reviews Endocrinology | Published online 1 Apr 2016; doi:10.1038/nrendo.2016.56
Hyunjae Lee
I N N O VAT I O N
Sweat-sensing patch for glucose
monitoring and drug delivery In a new study published in Nature one emulating hyperglycaemia), for injections) has been an idealized, Nanotechnology, Hyunjae Lee and thermal activation of the drug-loaded yet elusive, goal,” explains Kim. “Our colleagues report the development microneedles is triggered. study highlights the tremendous of a wearable, minimally invasive Sensitivity of the glucose sensor potential of sweat-based sensing of electrochemical device that couples was tested in two healthy volunteers glucose and microneedle-mediated real-time monitoring of glucose (men aged >20 years) who had no drug delivery for the management of levels in sweat with controlled history of diabetes mellitus. Levels of diabetes mellitus.” The investigators delivery of antidiabetic drugs glucose in sweat were measured over are currently working on improving through the skin. This technologi- a 24‑h period using the fabricated the sensitivity, reliability and reusa- cal advance brings one step closer patch and a commercial glucose assay bility of their device, with a view to point-of-care treatment for patients kit, and compared with blood glucose commercializing the technology. with diabetes mellitus. levels determined using a commercial In an accompanying commen- The investigators, led by Dae- glucose meter. The patch detected tary, Richard Guy of the University Hyeong Kim, used a gold–graphene elevated glucose levels after meals of Bath, UK, who was not involved hybrid material to fabricate a skin- (breakfast, lunch and dinner) and their in the study says “although the mounted device that incorporates subsequent decline due to normal holy grail of diabetes management modules for sweat collection, an insulin secretion. Furthermore, — a noninvasive feedback system enzyme-based glucose sensor (glu- statistical analysis confirmed a reliable combining glucose monitoring and cose oxidase) and a thermoresponsive correlation between sweat glucose responsive drug delivery — is not microneedle drug delivery system. measurements obtained with the patch yet at hand, Kim and co-workers The device is powered by a portable and the glucose assay, as well as with have certainly moved the field closer electrochemical analyser that the blood glucose readings (P <0.001 to this coveted prize.” As the tech- wirelessly transfers collected data to in both cases). Therapeutic efficacy of nology has the potential to reduce This mobile devices such as smartphones the device was tested in 8–10‑week-old the poor adherence to glucose technological and tablets. Additional sensors in the genetically diabetic (db/db) mice by monitoring prevalent in the diabetic device enable real-time correction laminating the patch (microneedles population, future developments are advance brings of sweat glucose measurements to preloaded with the glucose-lowering eagerly awaited. one step closer take account of changes in pH and drug, metformin) onto the skin of the David Holmes point-of-care temperature. Accuracy of glucose abdomen. Mice receiving metformin ORIGINAL ARTICLE Lee, H. et al. A graphene- treatment sensing is maintained by a humidity transcutaneously had significantly based electrochemical device with sensor, which activates the other lower blood glucose levels than control for patients sensors when the relative humidity in mice (patch without metformin or no thermoresponsive microneedles for diabetes monitoring and therapy. Nat. Nanotechnol. http:// with diabetes the patch exceeds 80% (the threshold patch; all P <0.05). dx.doi.org/10.1038/nnano.2016.38 (2016) FURTHER READING Guy, R. Diagnostic devices: mellitus value for accurate glucose sensing). “For a long time, pain-free glucose Managing diabetes through the skin. Nat. Upon reaching a predetermined monitoring and drug delivery (with- Nanotechnol. http://dx.doi.org/10.1038/ nnano.2016.53 (2016) glucose threshold (for example, out blood collection and the need
2018 - Noninvasive Monitoring of Blood Glucose Using Color-Coded Photoplethysmographic Images of The Illuminated Fingertip Within The Visible and Near-Infrared Range Opportunities and Questions